![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Drug-Drug Interactions Between Next Generation Direct Acting Antivirals
ABT-493 and ABT-530 with Cyclosporine or Tacrolimus in Healthy Subjects
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco, CA
Matthew P. Kosloski, Sandeep Dutta, Weihan Zhao, David Pugatch, Armen Asatryan, Jens Kort, Wei Liu AbbVie Inc., North Chicago, Illinois, United States
![AASLD1.gif](../images/111815/111815-5/AASLD1.gif)
![AASLD2.gif](../images/111815/111815-5/AASLD2.gif)
![AASLD3.gif](../images/111815/111815-5/AASLD3.gif)
![AASLD4.gif](../images/111815/111815-5/AASLD4.gif)
![AASLD5.gif](../images/111815/111815-5/AASLD5.gif)
![AASLD6.gif](../images/111815/111815-5/AASLD6.gif)
![AASLD7.gif](../images/111815/111815-5/AASLD7.gif)
![AASLD8.gif](../images/111815/111815-5/AASLD8.gif)
![AASLD9.gif](../images/111815/111815-5/AASLD9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|